Generate:Biomedicines raises $400M IPO, CEO talks about AI's future in drug design
Generate:Biomedicines完成4亿美元IPO，首席执行官谈AI在药物设计中的未来

A leader of the next wave of AI-driven biotechs completed one of the industry’s largest IPOs in years, although the milestone was tarnished by a rough first few hours of trading for the new stock.
作为新一波AI驱动生物科技的领军者之一，该公司完成了近年来业内规模最大的IPO之一，但这一里程碑因新股开盘后头几个小时的疲弱表现而打了折扣。